{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T06:31:52Z","timestamp":1787898712757,"version":"build-2784847793"},"reference-count":275,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,18]],"date-time":"2022-06-18T00:00:00Z","timestamp":1655510400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heliyon"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1016\/j.heliyon.2022.e09773","type":"journal-article","created":{"date-parts":[[2022,6,30]],"date-time":"2022-06-30T13:19:41Z","timestamp":1656595181000},"page":"e09773","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["Specific epigenetic regulators serve as potential therapeutic targets in idiopathic pulmonary fibrosis"],"prefix":"10.1016","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1126-9481","authenticated-orcid":false,"given":"Manas","family":"Sehgal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4209-5696","authenticated-orcid":false,"given":"Sharayu Manish","family":"Jakhete","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amruta Ganesh","family":"Manekar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2754-4492","authenticated-orcid":false,"given":"Satish","family":"Sasikumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.heliyon.2022.e09773_bib1","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1164\/rccm.2009-040GL","article-title":"A.C. on I.P. Fibrosis, An official ATS\/ERS\/JRS\/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management","volume":"183","author":"Raghu","year":"2011","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.heliyon.2022.e09773_bib2","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/s40266-016-0366-1","article-title":"Idiopathic pulmonary fibrosis and the elderly: diagnosis and management considerations","volume":"33","author":"Jo","year":"2016","journal-title":"Drugs Aging"},{"key":"10.1016\/j.heliyon.2022.e09773_bib3","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1186\/s12931-019-1161-4","article-title":"Antifibrotic therapy for idiopathic pulmonary fibrosis: time to treat","volume":"20","author":"Maher","year":"2019","journal-title":"Respir. Res."},{"key":"10.1016\/j.heliyon.2022.e09773_bib4","doi-asserted-by":"crossref","first-page":"2","DOI":"10.3390\/jcm6010002","article-title":"A\u00a0systematic review of the role of dysfunctional wound healing in the pathogenesis and treatment of idiopathic pulmonary fibrosis","volume":"6","author":"Betensley","year":"2016","journal-title":"J.\u00a0Clin. Med."},{"key":"10.1016\/j.heliyon.2022.e09773_bib5","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s12931-018-0730-2","article-title":"Idiopathic pulmonary fibrosis: pathogenesis and management","volume":"19","author":"Sgalla","year":"2018","journal-title":"Respir. Res."},{"key":"10.1016\/j.heliyon.2022.e09773_bib6","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1016\/S0140-6736(17)30866-8","article-title":"Idiopathic pulmonary fibrosis","volume":"389","author":"Richeldi","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.heliyon.2022.e09773_bib7","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1513\/pats.200601-003TK","article-title":"Role of epithelial cells in idiopathic pulmonary fibrosis","volume":"3","author":"Selman","year":"2006","journal-title":"Proc. Am. Thorac. Soc."},{"key":"10.1016\/j.heliyon.2022.e09773_bib8","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21093188","article-title":"Mechanisms of ATII-to-ATI cell differentiation during lung regeneration","volume":"21","author":"Aspal","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.heliyon.2022.e09773_bib9","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1172\/JCI38019","article-title":"Epithelial-mesenchymal transitions: the importance of changing cell state in development and disease","volume":"119","author":"Acloque","year":"2009","journal-title":"J.\u00a0Clin. Investig."},{"key":"10.1016\/j.heliyon.2022.e09773_bib10","doi-asserted-by":"crossref","first-page":"123","DOI":"10.3389\/fphar.2014.00123","article-title":"Fibroblasts in fibrosis: novel roles and mediators","volume":"5","author":"Kendall","year":"2014","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.heliyon.2022.e09773_bib11","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1172\/JCI93557","article-title":"Extracellular matrix as a driver of progressive fibrosis","volume":"128","author":"Herrera","year":"2018","journal-title":"J.\u00a0Clin. Investig."},{"key":"10.1016\/j.heliyon.2022.e09773_bib12","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1164\/rccm.201403-0509PP","article-title":"New therapeutic targets in idiopathic pulmonary fibrosis. Aiming to rein in runaway wound-healing responses","volume":"190","author":"Ahluwalia","year":"2014","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.heliyon.2022.e09773_bib13","doi-asserted-by":"crossref","first-page":"L405","DOI":"10.1152\/ajplung.00143.2013","article-title":"Grainyhead-like 2 (GRHL2) distribution reveals novel pathophysiological differences between human idiopathic pulmonary fibrosis and mouse models of pulmonary fibrosis","volume":"306","author":"Varma","year":"2014","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"key":"10.1016\/j.heliyon.2022.e09773_bib14","doi-asserted-by":"crossref","first-page":"132","DOI":"10.3892\/ijmm.2021.4965","article-title":"TGF-\u03b21: gentlemanly orchestrator in idiopathic pulmonary fibrosis (Review)","volume":"48","author":"Ye","year":"2021","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.heliyon.2022.e09773_bib15","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1186\/1479-5876-10-183","article-title":"TGF-\u03b2 \u2013 an excellent servant but a bad master","volume":"10","author":"Kubiczkova","year":"2012","journal-title":"J.\u00a0Transl. Med."},{"key":"10.1016\/j.heliyon.2022.e09773_bib16","doi-asserted-by":"crossref","first-page":"59","DOI":"10.3389\/fmed.2015.00059","article-title":"Signaling in fibrosis: TGF-\u03b2, WNT, and YAP\/TAZ converge","volume":"2","author":"Piersma","year":"2015","journal-title":"Front. Med."},{"key":"10.1016\/j.heliyon.2022.e09773_bib17","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1055\/s-0030-1255354","article-title":"Macrophages: master regulators of inflammation and fibrosis","volume":"30","author":"Wynn","year":"2010","journal-title":"Semin. Liver Dis."},{"key":"10.1016\/j.heliyon.2022.e09773_bib18","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1007\/s00281-016-0559-z","article-title":"The IL-1 cytokine family and its role in inflammation and fibrosis in the lung","volume":"38","author":"Borthwick","year":"2016","journal-title":"Semin. Immunopathol."},{"key":"10.1016\/j.heliyon.2022.e09773_bib19","doi-asserted-by":"crossref","first-page":"2863","DOI":"10.1172\/JCI45589","article-title":"Mouse and human lung fibroblasts regulate dendritic cell trafficking, airway inflammation, and fibrosis through integrin \u03b1v\u03b28-mediated activation of TGF-\u03b2","volume":"121","author":"Kitamura","year":"2011","journal-title":"J.\u00a0Clin. Investig."},{"key":"10.1016\/j.heliyon.2022.e09773_bib20","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/s12931-020-1319-0","article-title":"TGF-\u03b2 pathway activation by idiopathic pulmonary fibrosis (IPF) fibroblast derived soluble factors is mediated by IL-6 trans-signaling","volume":"21","author":"Epstein Shochet","year":"2020","journal-title":"Respir. Res."},{"key":"10.1016\/j.heliyon.2022.e09773_bib21","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1096\/fj.03-1273rev","article-title":"TGF-\u03b2 signaling and the fibrotic response","volume":"18","author":"Leask","year":"2004","journal-title":"FASEB J."},{"key":"10.1016\/j.heliyon.2022.e09773_bib22","doi-asserted-by":"crossref","first-page":"67","DOI":"10.2174\/157340810791233033","article-title":"TGF-\u03b2: titan of lung fibrogenesis","volume":"6","author":"Yue","year":"2010","journal-title":"Curr. Enzym. Inhib."},{"key":"10.1016\/j.heliyon.2022.e09773_bib23","doi-asserted-by":"crossref","first-page":"12684","DOI":"10.1016\/S0021-9258(18)99930-8","article-title":"Functional analysis of human alpha 1(I) procollagen gene promoter. Differential activity in collagen-producing and -nonproducing cells and response to transforming growth factor beta 1","volume":"269","author":"Jimenez","year":"1994","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.heliyon.2022.e09773_bib24","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1183\/09031936.01.00074101","article-title":"Type II alveolar epithelial cells and interstitial fibroblasts express connective tissue growth factor in IPF","volume":"17","author":"Pan","year":"2001","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.heliyon.2022.e09773_bib25","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1165\/rcmb.2003-0063OC","article-title":"Smad3 mediates transforming growth factor-\u03b2\u2013induced \u03b1-smooth muscle actin expression","volume":"29","author":"Hu","year":"2003","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.heliyon.2022.e09773_bib26","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1089\/dna.2009.0884","article-title":"Transforming growth factor-beta1 up-regulation of human alpha(1)(I) collagen is mediated by Sp1 and Smad2 transacting factors","volume":"28","author":"Sysa","year":"2009","journal-title":"DNA Cell Biol."},{"key":"10.1016\/j.heliyon.2022.e09773_bib27","first-page":"848","article-title":"Signaling mechanisms of myofibroblastic activation: outside-in and inside-out, cellular physiology and biochemistry","volume":"49","author":"Zent","year":"2018","journal-title":"Int. J. Exp. Cel. Physiol. Biochem. Pharmacol."},{"key":"10.1016\/j.heliyon.2022.e09773_bib28","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1172\/JCI200419603","article-title":"Imatinib mesylate inhibits the profibrogenic activity of TGF-beta and prevents bleomycin-mediated lung fibrosis","volume":"114","author":"Daniels","year":"2004","journal-title":"J.\u00a0Clin. Investig."},{"key":"10.1016\/j.heliyon.2022.e09773_bib29","article-title":"CXCL12 induces connective tissue growth factor expression in human lung fibroblasts through the Rac1\/ERK, JNK, and AP-1 pathways","volume":"9","author":"Lin","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.heliyon.2022.e09773_bib30","article-title":"IL-13 induces YY1 through the AKT pathway in lung fibroblasts","volume":"10","author":"Guo","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.heliyon.2022.e09773_bib31","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1096\/fj.15-273953","article-title":"STAT-3 contributes to pulmonary fibrosis through epithelial injury and fibroblast-myofibroblast differentiation","volume":"30","author":"Pedroza","year":"2016","journal-title":"FASEB J."},{"key":"10.1016\/j.heliyon.2022.e09773_bib32","doi-asserted-by":"crossref","first-page":"2733","DOI":"10.1016\/j.celrep.2016.05.051","article-title":"SET9-Mediated regulation of TGF-\u03b2 signaling links protein methylation to pulmonary fibrosis","volume":"15","author":"Elkouris","year":"2016","journal-title":"Cell Rep."},{"key":"10.1016\/j.heliyon.2022.e09773_bib33","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s12929-018-0421-9","article-title":"MEKK1, JNK, and SMAD3 mediate CXCL12-stimulated connective tissue growth factor expression in human lung fibroblasts","volume":"25","author":"Lin","year":"2018","journal-title":"J.\u00a0Biomed. Sci."},{"key":"10.1016\/j.heliyon.2022.e09773_bib34","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.semcdb.2019.11.013","article-title":"Non-canonical (non-SMAD2\/3) TGF-\u03b2 signaling in fibrosis: mechanisms and targets","volume":"101","author":"Finnson","year":"2020","journal-title":"Semin. Cell Dev. Biol."},{"key":"10.1016\/j.heliyon.2022.e09773_bib35","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.3390\/biom10121666","article-title":"Transforming growth factor-\u03b2 signaling in fibrotic diseases and cancer-associated fibroblasts","volume":"10","author":"Shi","year":"2020","journal-title":"Biomolecules"},{"key":"10.1016\/j.heliyon.2022.e09773_bib36","doi-asserted-by":"crossref","first-page":"6107","DOI":"10.3390\/ijms22116107","article-title":"Molecular pathogenesis of pulmonary fibrosis, with focus on pathways related to TGF-\u03b2 and the ubiquitin-proteasome pathway","volume":"22","author":"Inui","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.heliyon.2022.e09773_bib37","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1165\/rcmb.2008-0447OC","article-title":"Endothelin-1 and transforming growth factor-\u03b21 independently induce fibroblast resistance to apoptosis via AKT activation","volume":"41","author":"Kulasekaran","year":"2009","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.heliyon.2022.e09773_bib38","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1172\/JCI6094","article-title":"Transient gene transfer and expression of Smad7 prevents bleomycin-induced lung fibrosis in mice","volume":"104","author":"Nakao","year":"1999","journal-title":"J.\u00a0Clin. Investig."},{"key":"10.1016\/j.heliyon.2022.e09773_bib39","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1513\/pats.200605-125SF","article-title":"Smad3 signaling involved in pulmonary fibrosis and emphysema","volume":"3","author":"Gauldie","year":"2006","journal-title":"Proc. Am. Thorac. Soc."},{"key":"10.1016\/j.heliyon.2022.e09773_bib40","doi-asserted-by":"crossref","first-page":"2841","DOI":"10.4161\/cc.9.14.12268","article-title":"Signaling pathways in the epithelial origins of pulmonary fibrosis","volume":"9","author":"Hardie","year":"2010","journal-title":"Cell Cycle"},{"key":"10.1016\/j.heliyon.2022.e09773_bib41","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1183\/09031936.00163814","article-title":"The genetic basis of idiopathic pulmonary fibrosis","volume":"45","author":"Kropski","year":"2015","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.heliyon.2022.e09773_bib42","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1186\/s12890-019-0895-6","article-title":"Clinical characteristics of patients with familial idiopathic pulmonary fibrosis (f-IPF)","volume":"19","author":"Krauss","year":"2019","journal-title":"BMC Pulm. Med."},{"key":"10.1016\/j.heliyon.2022.e09773_bib43","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.trsl.2014.03.011","article-title":"Epigenetics of idiopathic pulmonary fibrosis","volume":"165","author":"Yang","year":"2015","journal-title":"Transl. Res. : J. Lab. Clin. Med."},{"key":"10.1016\/j.heliyon.2022.e09773_bib44","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00545-2017","article-title":"A\u00a0recurring theme in pulmonary fibrosis genetics","volume":"49","author":"Wolters","year":"2017","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.heliyon.2022.e09773_bib45","first-page":"7","article-title":"Epigenetics and chromatin remodeling play a role in lung disease","volume":"10","author":"Mortaz","year":"2011","journal-title":"Tanaffos"},{"key":"10.1016\/j.heliyon.2022.e09773_bib46","doi-asserted-by":"crossref","first-page":"21065","DOI":"10.1074\/jbc.M802786200","article-title":"Requirement of HDAC6 for transforming growth factor-beta1-induced epithelial-mesenchymal transition","volume":"283","author":"Shan","year":"2008","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.heliyon.2022.e09773_bib47","doi-asserted-by":"crossref","first-page":"L864","DOI":"10.1152\/ajplung.00128.2009","article-title":"Abrogation of TGF-\u03b21-induced fibroblast-myofibroblast differentiation by histone deacetylase inhibition","volume":"297","author":"Guo","year":"2009","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"key":"10.1016\/j.heliyon.2022.e09773_bib48","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1165\/rcmb.2014-0150OC","article-title":"Pathologic regulation of collagen I by an aberrant protein phosphatase 2A\/histone deacetylase C4\/MicroRNA-29 signal Axis in idiopathic pulmonary fibrosis fibroblasts","volume":"53","author":"Khalil","year":"2015","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.heliyon.2022.e09773_bib49","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1136\/thoraxjnl-2014-206411","article-title":"Aberrant expression and activity of histone deacetylases in sporadic idiopathic pulmonary fibrosis","volume":"70","author":"Korfei","year":"2015","journal-title":"Thorax"},{"key":"10.1016\/j.heliyon.2022.e09773_bib50","doi-asserted-by":"crossref","first-page":"L936","DOI":"10.1152\/ajplung.00256.2016","article-title":"TGF-\u03b21 stimulates HDAC4 nucleus-to-cytoplasm translocation and NADPH oxidase 4-derived reactive oxygen species in normal human lung fibroblasts","volume":"312","author":"Guo","year":"2017","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"key":"10.1016\/j.heliyon.2022.e09773_bib51","doi-asserted-by":"crossref","first-page":"L175","DOI":"10.1152\/ajplung.00551.2017","article-title":"HDAC8 inhibition ameliorates pulmonary fibrosis","volume":"316","author":"Saito","year":"2019","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"key":"10.1016\/j.heliyon.2022.e09773_bib52","doi-asserted-by":"crossref","first-page":"jcs233486","DOI":"10.1242\/jcs.233486","article-title":"TGF\u03b2-induced fibroblast activation requires persistent and targeted HDAC-mediated gene repression","volume":"132","author":"Jones","year":"2019","journal-title":"J.\u00a0Cell Sci."},{"key":"10.1016\/j.heliyon.2022.e09773_bib53","doi-asserted-by":"crossref","DOI":"10.1177\/2040622319862697","article-title":"HDAC inhibitors as antifibrotic drugs in cardiac and pulmonary fibrosis","volume":"10","author":"Lyu","year":"2019","journal-title":"Therapeutic Advances in Chronic Disease"},{"key":"10.1016\/j.heliyon.2022.e09773_bib54","doi-asserted-by":"crossref","first-page":"a018713","DOI":"10.1101\/cshperspect.a018713","article-title":"Erasers of histone acetylation: the histone deacetylase enzymes","volume":"6","author":"Seto","year":"2014","journal-title":"Cold Spring Harbor Perspect. Biol."},{"key":"10.1016\/j.heliyon.2022.e09773_bib55","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.bbagrm.2008.06.005","article-title":"Chemical mechanisms of histone lysine and arginine modifications","volume":"1789","author":"Smith","year":"2009","journal-title":"Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms"},{"key":"10.1016\/j.heliyon.2022.e09773_bib56","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/s12276-020-0382-4","article-title":"A\u00a0short guide to histone deacetylases including recent progress on class II enzymes","volume":"52","author":"Park","year":"2020","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.heliyon.2022.e09773_bib57","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/sj.cr.7310149","article-title":"HDACs, histone deacetylation and gene transcription: from molecular biology to cancer therapeutics","volume":"17","author":"Gallinari","year":"2007","journal-title":"Cell Res."},{"key":"10.1016\/j.heliyon.2022.e09773_bib58","article-title":"Physical and functional HAT\/HDAC interplay regulates protein acetylation balance","author":"Peserico","year":"2011","journal-title":"J.\u00a0Biomed. Biotechnol."},{"key":"10.1016\/j.heliyon.2022.e09773_bib59","first-page":"53","article-title":"Transcription regulation by class III histone deacetylases (HDACs)-Sirtuins","volume":"3","author":"Dai","year":"2008","journal-title":"Transl. Oncogenomics"},{"key":"10.1016\/j.heliyon.2022.e09773_bib60","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1868-7083-4-5","article-title":"Roles of histone deacetylases in epigenetic regulation: emerging paradigms from studies with inhibitors","volume":"4","author":"Delcuve","year":"2012","journal-title":"Clin. Epigenet."},{"key":"10.1016\/j.heliyon.2022.e09773_bib61","doi-asserted-by":"crossref","first-page":"7202","DOI":"10.1073\/pnas.97.13.7202","article-title":"The histone deacetylase-3 complex contains nuclear receptor corepressors","volume":"97","author":"Wen","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.heliyon.2022.e09773_bib62","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1096\/fj.04-2303fje","article-title":"Histone deacetylase HDAC8 associates with smooth muscle \u03b1-actin and is essential for smooth muscle cell contractility","volume":"19","author":"Waltregny","year":"2005","journal-title":"FASEB J."},{"key":"10.1016\/j.heliyon.2022.e09773_bib63","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/nature07925","article-title":"HDAC2 negatively regulates memory formation and synaptic plasticity","volume":"459","author":"Guan","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.heliyon.2022.e09773_bib64","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.exger.2009.10.001","article-title":"Role of HDAC1 in senescence, aging, and cancer","volume":"45","author":"Willis-Martinez","year":"2010","journal-title":"Exp. Gerontol."},{"key":"10.1016\/j.heliyon.2022.e09773_bib65","doi-asserted-by":"crossref","first-page":"20092","DOI":"10.18632\/oncotarget.15383","article-title":"HDAC8 functions in spindle assembly during mouse oocyte meiosis","volume":"8","author":"Zhang","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.heliyon.2022.e09773_bib66","doi-asserted-by":"crossref","first-page":"537","DOI":"10.3389\/fphar.2020.00537","article-title":"Histone deacetylases inhibitors in neurodegenerative diseases, neuroprotection and neuronal differentiation","volume":"11","author":"Shukla","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.heliyon.2022.e09773_bib67","article-title":"The roles of histone deacetylases and their inhibitors in cancer therapy","volume":"8","author":"Li","year":"2020","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.heliyon.2022.e09773_bib68","doi-asserted-by":"crossref","first-page":"17007","DOI":"10.1074\/jbc.M101508200","article-title":"A\u00a0dynamic role for HDAC7 in MEF2-mediated muscle differentiation","volume":"276","author":"Dressel","year":"2001","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.heliyon.2022.e09773_bib69","doi-asserted-by":"crossref","first-page":"35826","DOI":"10.1074\/jbc.M104935200","article-title":"Human HDAC7 histone deacetylase activity is associated with HDAC3 in vivo","volume":"276","author":"Fischle","year":"2001","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.heliyon.2022.e09773_bib70","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1161\/CIRCRESAHA.107.149377","article-title":"Histone deacetylase 7 silencing alters endothelial cell migration, a key step in angiogenesis","volume":"101","author":"Mottet","year":"2007","journal-title":"Circ. Res."},{"key":"10.1016\/j.heliyon.2022.e09773_bib71","doi-asserted-by":"crossref","first-page":"5669","DOI":"10.1182\/blood-2009-01-196485","article-title":"HDAC5 is a repressor of angiogenesis and determines the angiogenic gene expression pattern of endothelial cells","volume":"113","author":"Urbich","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.heliyon.2022.e09773_bib72","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.cell.2012.09.037","article-title":"HDAC4 governs a transcriptional program essential for synaptic plasticity and memory","volume":"151","author":"Sando","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.heliyon.2022.e09773_bib73","doi-asserted-by":"crossref","first-page":"139","DOI":"10.2217\/epi.13.73","article-title":"HDAC4: mechanism of regulation and biological functions","volume":"6","author":"Wang","year":"2014","journal-title":"Epigenomics"},{"key":"10.1016\/j.heliyon.2022.e09773_bib74","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.15252\/embr.201439195","article-title":"HDAC4 promotes Pax7-dependent satellite cell activation and muscle regeneration","volume":"15","author":"Choi","year":"2014","journal-title":"EMBO Rep."},{"key":"10.1016\/j.heliyon.2022.e09773_bib75","doi-asserted-by":"crossref","first-page":"42","DOI":"10.3389\/fncel.2015.00042","article-title":"HDAC4 as a potential therapeutic target in neurodegenerative diseases: a summary of recent achievements","volume":"9","author":"Mielcarek","year":"2015","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.heliyon.2022.e09773_bib76","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms10782","article-title":"Hypothalamic leptin action is mediated by histone deacetylase 5","volume":"7","author":"Kabra","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.heliyon.2022.e09773_bib77","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1186\/s12943-017-0736-2","article-title":"Hdac7 promotes lung tumorigenesis by inhibiting Stat3 activation","volume":"16","author":"Lei","year":"2017","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.heliyon.2022.e09773_bib78","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1007\/s13402-021-00626-9","article-title":"Histone deacetylase (HDAC) 9: versatile biological functions and emerging roles in human cancer","volume":"44","author":"Yang","year":"2021","journal-title":"Cell. Oncol."},{"key":"10.1016\/j.heliyon.2022.e09773_bib79","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2021.101380","article-title":"Histone deacetylase 5 deacetylates the phosphatase PP2A for positively regulating NF-\u03baB signaling","volume":"297","author":"Xu","year":"2021","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.heliyon.2022.e09773_bib80","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/417455a","article-title":"HDAC6 is a microtubule-associated deacetylase","volume":"417","author":"Hubbert","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.heliyon.2022.e09773_bib81","doi-asserted-by":"crossref","first-page":"59388","DOI":"10.18632\/oncotarget.10673","article-title":"HDAC10 promotes lung cancer proliferation via AKT phosphorylation","volume":"7","author":"Yang","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.heliyon.2022.e09773_bib82","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms15368","article-title":"Histone deacetylase 10 structure and molecular function as a polyamine deacetylase","volume":"8","author":"Hai","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.heliyon.2022.e09773_bib83","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1186\/s10020-021-00375-3","article-title":"Posttranslational modification and beyond: interplay between histone deacetylase 6 and heat-shock protein 90","volume":"27","author":"Liu","year":"2021","journal-title":"Mol. Med."},{"key":"10.1016\/j.heliyon.2022.e09773_bib84","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/j.molcel.2013.05.012","article-title":"SIRT4 coordinates the balance between lipid synthesis and catabolism by repressing malonyl CoA decarboxylase","volume":"50","author":"Laurent","year":"2013","journal-title":"Mol. Cell"},{"key":"10.1016\/j.heliyon.2022.e09773_bib85","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.tibs.2013.12.002","article-title":"Chromatin and beyond: the multitasking roles for SIRT6","volume":"39","author":"Kugel","year":"2014","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.heliyon.2022.e09773_bib86","doi-asserted-by":"crossref","first-page":"5011","DOI":"10.1038\/ncomms6011","article-title":"SIRT6 represses LINE1 retrotransposons by ribosylating KAP1 but this repression fails with stress and age","volume":"5","author":"van Meter","year":"2014","journal-title":"Nat. Commun."},{"key":"10.1016\/j.heliyon.2022.e09773_bib87","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1126\/science.aac4854","article-title":"NAD+ in aging, metabolism, and neurodegeneration","volume":"350","author":"Eric","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.heliyon.2022.e09773_bib88","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1021\/acschembio.5b01084","article-title":"SIRT7 is activated by DNA and deacetylates histone H3 in the chromatin context","volume":"11","author":"Tong","year":"2016","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.heliyon.2022.e09773_bib89","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1021\/acschembio.6b00954","article-title":"SIRT7 is an RNA-activated protein lysine deacylase","volume":"12","author":"Tong","year":"2017","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.heliyon.2022.e09773_bib90","doi-asserted-by":"crossref","first-page":"614","DOI":"10.3389\/fendo.2018.00614","article-title":"High levels of SIRT1 expression as a protective mechanism against disease-related conditions","volume":"9","author":"Elibol","year":"2018","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.heliyon.2022.e09773_bib91","doi-asserted-by":"crossref","first-page":"799","DOI":"10.3389\/fnins.2018.00799","article-title":"SIRT3 regulation under cellular stress: making sense of the ups and downs","volume":"12","author":"Marcus","year":"2018","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.heliyon.2022.e09773_bib92","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1016\/j.bbamcr.2018.06.005","article-title":"SIRT2 reduces actin polymerization and cell migration through deacetylation and degradation of HSP90","volume":"1865","author":"Min","year":"2018","journal-title":"Biochim. Biophys. Acta Mol. Cell Res."},{"key":"10.1016\/j.heliyon.2022.e09773_bib93","doi-asserted-by":"crossref","first-page":"652","DOI":"10.3389\/fendo.2018.00652","article-title":"Advances in cellular characterization of the sirtuin isoform, SIRT7","volume":"9","author":"Wu","year":"2018","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.heliyon.2022.e09773_bib94","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1089\/ars.2017.7290","article-title":"The role of Sirtuins in antioxidant and redox signaling","volume":"28","author":"Singh","year":"2018","journal-title":"Antioxidants Redox Signal."},{"key":"10.1016\/j.heliyon.2022.e09773_bib95","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1080\/10409238.2018.1458071","article-title":"Functions of the sirtuin deacylase SIRT5 in normal physiology and pathobiology","volume":"53","author":"Kumar","year":"2018","journal-title":"Crit. Rev. Biochem. Mol. Biol."},{"key":"10.1016\/j.heliyon.2022.e09773_bib96","doi-asserted-by":"crossref","first-page":"778","DOI":"10.3389\/fnins.2018.00778","article-title":"Sirtuins in neuroendocrine regulation and neurological diseases","volume":"12","author":"Fujita","year":"2018","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.heliyon.2022.e09773_bib97","doi-asserted-by":"crossref","first-page":"783","DOI":"10.3389\/fendo.2018.00783","article-title":"The roles of mitochondrial SIRT4 in cellular metabolism","volume":"9","author":"Min","year":"2019","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.heliyon.2022.e09773_bib98","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.cmet.2019.02.014","article-title":"LINE1 derepression in aged wild-type and SIRT6-deficient mice drives inflammation","volume":"29","author":"Simon","year":"2019","journal-title":"Cell Metabol."},{"key":"10.1016\/j.heliyon.2022.e09773_bib99","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1152\/physrev.00030.2018","article-title":"SIRT6, a mammalian deacylase with multitasking abilities","volume":"100","author":"Chang","year":"2020","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.heliyon.2022.e09773_bib100","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.118201","article-title":"Sirtuins as endogenous regulators of lung fibrosis: a current perspective","volume":"258","author":"Mazumder","year":"2020","journal-title":"Life Sci."},{"key":"10.1016\/j.heliyon.2022.e09773_bib101","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/ni.1673","article-title":"The histone deacetylase HDAC11 regulates the expression of interleukin 10 and immune tolerance","volume":"10","author":"Villagra","year":"2009","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.heliyon.2022.e09773_bib102","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/978-1-4939-3667-0_11","article-title":"Functional analysis of histone deacetylase 11 (HDAC11)","volume":"1436","author":"Chen","year":"2016","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.heliyon.2022.e09773_bib103","doi-asserted-by":"crossref","first-page":"42","DOI":"10.7861\/clinmedicine.16-1-42","article-title":"Therapeutic advances in idiopathic pulmonary fibrosis","volume":"16","author":"Fraser","year":"2016","journal-title":"Clin. Med."},{"key":"10.1016\/j.heliyon.2022.e09773_bib104","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1080\/14728214.2018.1471465","article-title":"An update on emerging drugs for the treatment of idiopathic pulmonary fibrosis","volume":"23","author":"Aryal","year":"2018","journal-title":"Expet Opin. Emerg. Drugs"},{"key":"10.1016\/j.heliyon.2022.e09773_bib105","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/j.1476-5381.2011.01247.x","article-title":"Novel therapeutic approaches for pulmonary fibrosis","volume":"163","author":"Datta","year":"2011","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.heliyon.2022.e09773_bib106","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1183\/09059180.00001111","article-title":"Antifibrotic activities of pirfenidone in animal models","volume":"20","author":"Schaefer","year":"2011","journal-title":"Eur. Respir. Rev."},{"key":"10.1016\/j.heliyon.2022.e09773_bib107","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1165\/rcmb.2016-0217OC","article-title":"A\u00a0novel antifibrotic mechanism of nintedanib and pirfenidone. Inhibition of collagen fibril assembly","volume":"57","author":"Kn\u00fcppel","year":"2017","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.heliyon.2022.e09773_bib108","doi-asserted-by":"crossref","first-page":"361","DOI":"10.2147\/PPA.S37233","article-title":"Efficacy and safety of pirfenidone for idiopathic pulmonary fibrosis","volume":"8","author":"Takeda","year":"2014","journal-title":"Patient Prefer. Adherence"},{"key":"10.1016\/j.heliyon.2022.e09773_bib109","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1186\/s12931-019-1093-z","article-title":"Pirfenidone attenuates lung fibrotic fibroblast responses to transforming growth factor-\u03b21","volume":"20","author":"Jin","year":"2019","journal-title":"Respir. Res."},{"key":"10.1016\/j.heliyon.2022.e09773_bib110","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1183\/09031936.00174914","article-title":"Mode of action of nintedanib in the treatment of idiopathic pulmonary fibrosis","volume":"45","author":"Wollin","year":"2015","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.heliyon.2022.e09773_bib111","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1186\/s12931-017-0654-2","article-title":"Anti-fibrotic efficacy of nintedanib in pulmonary fibrosis via the inhibition of fibrocyte activity","volume":"18","author":"Sato","year":"2017","journal-title":"Respir. Res."},{"key":"10.1016\/j.heliyon.2022.e09773_bib112","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1186\/s12931-014-0157-3","article-title":"Anti-fibrotic effects of nintedanib in lung fibroblasts derived from patients with idiopathic pulmonary fibrosis","volume":"15","author":"Hostettler","year":"2014","journal-title":"Respir. Res."},{"key":"10.1016\/j.heliyon.2022.e09773_bib113","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s12931-019-0977-2","article-title":"Effect of pirfenidone on lung function decline and survival: 5-yr experience from a real-life IPF cohort from the Czech EMPIRE registry","volume":"20","author":"Zurkova","year":"2019","journal-title":"Respir. Res."},{"key":"10.1016\/j.heliyon.2022.e09773_bib114","doi-asserted-by":"crossref","first-page":"78","DOI":"10.3390\/jcm5090078","article-title":"Real world experiences: pirfenidone and nintedanib are effective and well tolerated treatments for idiopathic pulmonary fibrosis","volume":"5","author":"Hughes","year":"2016","journal-title":"J.\u00a0Clin. Med."},{"key":"10.1016\/j.heliyon.2022.e09773_bib115","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2020.581828","article-title":"Long-term follow-up of patients with idiopathic pulmonary fibrosis treated with pirfenidone or nintedanib: a real-life comparison study","volume":"7","author":"Cameli","year":"2020","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.heliyon.2022.e09773_bib116","first-page":"68","article-title":"Lung transplantation in idiopathic pulmonary fibrosis","volume":"6","author":"Laporta Hernandez","year":"2018","journal-title":"Med. Sci."},{"key":"10.1016\/j.heliyon.2022.e09773_bib117","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1513\/pats.200602-021TK","article-title":"Targeting genes for treatment in idiopathic pulmonary fibrosis: challenges and opportunities, promises and pitfalls","volume":"3","author":"Ask","year":"2006","journal-title":"Proc. Am. Thorac. Soc."},{"key":"10.1016\/j.heliyon.2022.e09773_bib118","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.pharmthera.2018.02.010","article-title":"Safer approaches to therapeutic modulation of TGF-\u03b2 signaling for respiratory disease","volume":"187","author":"Lachapelle","year":"2018","journal-title":"Pharmacol. Therapeut."},{"key":"10.1016\/j.heliyon.2022.e09773_bib119","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/j.immuni.2019.03.024","article-title":"Transforming growth factor-\u03b2 signaling in immunity and cancer","volume":"50","author":"Batlle","year":"2019","journal-title":"Immunity"},{"key":"10.1016\/j.heliyon.2022.e09773_bib120","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1124\/jpet.110.168385","article-title":"Histone deacetylase: a potential therapeutic target for fibrotic disorders","volume":"335","author":"Pang","year":"2010","journal-title":"J.\u00a0Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.heliyon.2022.e09773_bib121","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.3390\/ijms20061329","article-title":"HDAC inhibitors: therapeutic potential in fibrosis-associated human diseases","volume":"20","author":"Yoon","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.heliyon.2022.e09773_bib122","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.118201","article-title":"Sirtuins as endogenous regulators of lung fibrosis: a current perspective","volume":"258","author":"Mazumder","year":"2020","journal-title":"Life Sci."},{"key":"10.1016\/j.heliyon.2022.e09773_bib123","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1183\/09031936.00095113","article-title":"Histone deacetylase inhibition promotes fibroblast apoptosis and ameliorates pulmonary fibrosis in mice","volume":"43","author":"Sanders","year":"2014","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.heliyon.2022.e09773_bib124","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1046\/j.1440-1827.2003.01446.x","article-title":"Pulmonary fibrosis: cellular and molecular events","volume":"53","author":"Razzaque","year":"2003","journal-title":"Pathol. Int."},{"key":"10.1016\/j.heliyon.2022.e09773_bib125","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1183\/09059180.00002114","article-title":"Staging of idiopathic pulmonary fibrosis: past, present and future","volume":"23","author":"Kolb","year":"2014","journal-title":"Eur. Respir. Rev."},{"key":"10.1016\/j.heliyon.2022.e09773_bib126","doi-asserted-by":"crossref","first-page":"6255","DOI":"10.3390\/ijms22126255","article-title":"Molecular biomarkers in idiopathic pulmonary fibrosis: state of the art and future directions","volume":"22","author":"Stainer","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.heliyon.2022.e09773_bib127","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1183\/09031936.00073012","article-title":"The pathogenesis of pulmonary fibrosis: a moving target","volume":"41","author":"Wuyts","year":"2013","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.heliyon.2022.e09773_bib128","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20171301","article-title":"Potential contribution of alveolar epithelial type I cells to pulmonary fibrosis","volume":"37","author":"Kasper","year":"2017","journal-title":"Biosci. Rep."},{"key":"10.1016\/j.heliyon.2022.e09773_bib129","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/S0140-6736(12)61144-1","article-title":"New cellular and molecular mechanisms of lung injury and fibrosis in idiopathic pulmonary fibrosis","volume":"380","author":"Fernandez","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.heliyon.2022.e09773_bib130","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.1513\/AnnalsATS.201410-448MG","article-title":"Mechanisms of alveolar epithelial injury, repair, and fibrosis","volume":"12","author":"Chambers","year":"2015","journal-title":"Annals of the American Thoracic Society"},{"key":"10.1016\/j.heliyon.2022.e09773_bib131","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1146\/annurev-physiol-020518-114320","article-title":"Cell death in the lung: the apoptosis-necroptosis axis","volume":"81","author":"Sauler","year":"2019","journal-title":"Annu. Rev. Physiol."},{"key":"10.1016\/j.heliyon.2022.e09773_bib132","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1378\/chest.127.1.266","article-title":"Expression of apoptotic and antiapoptotic markers in epithelial cells in idiopathic pulmonary fibrosis","volume":"127","author":"Plataki","year":"2005","journal-title":"Chest"},{"key":"10.1016\/j.heliyon.2022.e09773_bib133","doi-asserted-by":"crossref","first-page":"6470","DOI":"10.4049\/jimmunol.168.12.6470","article-title":"TGF-\u03b21 as an enhancer of Fas-mediated apoptosis of lung epithelial cells","volume":"168","author":"Hagimoto","year":"2002","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.heliyon.2022.e09773_bib134","doi-asserted-by":"crossref","first-page":"427","DOI":"10.2174\/156652408785160943","article-title":"Interaction of TGF-\u03b2 with immune cells in airway disease","volume":"8","author":"Moore","year":"2008","journal-title":"Curr. Mol. Med."},{"key":"10.1016\/j.heliyon.2022.e09773_bib135","doi-asserted-by":"crossref","first-page":"173","DOI":"10.3389\/fphar.2013.00173","article-title":"The epithelium in idiopathic pulmonary fibrosis: breaking the barrier","volume":"4","author":"Camelo","year":"2014","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.heliyon.2022.e09773_bib136","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1172\/JCI5628","article-title":"Essential roles of the Fas-Fas ligand pathway in the development of pulmonary fibrosis","volume":"104","author":"Kuwano","year":"1999","journal-title":"J.\u00a0Clin. Investig."},{"key":"10.1016\/j.heliyon.2022.e09773_bib137","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s12931-014-0162-6","article-title":"Conditional overexpression of TGF\u03b21 promotes pulmonary inflammation, apoptosis and mortality via TGF\u03b2R2 in the developing mouse lung","volume":"16","author":"Sureshbabu","year":"2015","journal-title":"Respir. Res."},{"key":"10.1016\/j.heliyon.2022.e09773_bib138","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1186\/s12890-021-01749-3","article-title":"Integrative analysis of lung molecular signatures reveals key drivers of idiopathic pulmonary fibrosis","volume":"21","author":"Kim","year":"2021","journal-title":"BMC Pulm. Med."},{"key":"10.1016\/j.heliyon.2022.e09773_bib139","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1016\/S0002-9440(10)62351-6","article-title":"Induction of epithelial-mesenchymal transition in alveolar epithelial cells by transforming growth factor-beta1: potential role in idiopathic pulmonary fibrosis","volume":"166","author":"Willis","year":"2005","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.heliyon.2022.e09773_bib140","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1513\/pats.200601-001TK","article-title":"Evolving concepts of apoptosis in idiopathic pulmonary fibrosis","volume":"3","author":"Thannickal","year":"2006","journal-title":"Proc. Am. Thorac. Soc."},{"key":"10.1016\/j.heliyon.2022.e09773_bib141","doi-asserted-by":"crossref","first-page":"83","DOI":"10.3390\/medicina55040083","article-title":"Epithelial-mesenchymal transition in the pathogenesis of idiopathic pulmonary fibrosis","volume":"55","author":"Salton","year":"2019","journal-title":"Medicina (Kaunas, Lithuania)"},{"key":"10.1016\/j.heliyon.2022.e09773_bib142","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1172\/JCI39104","article-title":"The basics of epithelial-mesenchymal transition","volume":"119","author":"Kalluri","year":"2009","journal-title":"J.\u00a0Clin. Investig."},{"key":"10.1016\/j.heliyon.2022.e09773_bib143","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2020.607483","article-title":"The epithelial-to-mesenchymal transition as a possible therapeutic target in fibrotic disorders","volume":"8","author":"Di Gregorio","year":"2020","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.heliyon.2022.e09773_bib144","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1513\/pats.200601-004TK","article-title":"Epithelial origin of myofibroblasts during fibrosis in the lung","volume":"3","author":"Willis","year":"2006","journal-title":"Proc. Am. Thorac. Soc."},{"key":"10.1016\/j.heliyon.2022.e09773_bib145","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1183\/09059180.00004413","article-title":"Tissue remodelling in chronic bronchial diseases: from the epithelial to mesenchymal phenotype","volume":"23","author":"Pain","year":"2014","journal-title":"Eur. Respir. Rev."},{"key":"10.1016\/j.heliyon.2022.e09773_bib146","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.2005189","article-title":"Signaling mechanisms of the epithelial-mesenchymal transition","volume":"7","author":"Gonzalez","year":"2014","journal-title":"Sci. Signal."},{"key":"10.1016\/j.heliyon.2022.e09773_bib147","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1159\/000489367","article-title":"Histone deacetylases promote ER stress induced epithelial mesenchymal transition in human lung epithelial cells","volume":"46","author":"Liu","year":"2018","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.heliyon.2022.e09773_bib148","doi-asserted-by":"crossref","first-page":"4322","DOI":"10.18632\/aging.102882","article-title":"Sirt1 antisense long non-coding RNA attenuates pulmonary fibrosis through sirt1-mediated epithelial-mesenchymal transition","volume":"12","author":"Qian","year":"2020","journal-title":"Aging"},{"key":"10.1016\/j.heliyon.2022.e09773_bib149","doi-asserted-by":"crossref","first-page":"4354","DOI":"10.1111\/jcmm.13725","article-title":"Astragaloside IV modulates TGF-\u03b21-dependent epithelial-mesenchymal transition in bleomycin-induced pulmonary fibrosis","volume":"22","author":"Qian","year":"2018","journal-title":"J.\u00a0Cell Mol. Med."},{"key":"10.1016\/j.heliyon.2022.e09773_bib150","doi-asserted-by":"crossref","first-page":"10501","DOI":"10.1111\/jcmm.15665","article-title":"Andrographolide attenuates epithelial-mesenchymal transition induced by TGF-\u03b21 in alveolar epithelial cells","volume":"24","author":"Li","year":"2020","journal-title":"J.\u00a0Cell Mol. Med."},{"key":"10.1016\/j.heliyon.2022.e09773_bib151","doi-asserted-by":"crossref","first-page":"L525","DOI":"10.1152\/ajplung.00163.2007","article-title":"TGF-\u03b2-induced EMT: mechanisms and implications for fibrotic lung disease","volume":"293","author":"Willis","year":"2007","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"key":"10.1016\/j.heliyon.2022.e09773_bib152","first-page":"517","article-title":"EMT and interstitial lung disease: a mysterious relationship","volume":"18","author":"Kage","year":"2012","journal-title":"Curr. Opin. Pulm. Med."},{"key":"10.1016\/j.heliyon.2022.e09773_bib153","doi-asserted-by":"crossref","first-page":"e20190103","DOI":"10.1084\/jem.20190103","article-title":"Transforming growth factor-\u03b2 in tissue fibrosis","volume":"217","author":"Frangogiannis","year":"2020","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.heliyon.2022.e09773_bib154","doi-asserted-by":"crossref","first-page":"5353","DOI":"10.1093\/emboj\/16.17.5353","article-title":"TGF-\u03b2 receptor-mediated signalling through Smad2, Smad3 and Smad4","volume":"16","author":"Nakao","year":"1997","journal-title":"EMBO J."},{"key":"10.1016\/j.heliyon.2022.e09773_bib155","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1038\/nrm3758","article-title":"Molecular mechanisms of epithelial-mesenchymal transition","volume":"15","author":"Lamouille","year":"2014","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.heliyon.2022.e09773_bib156","doi-asserted-by":"crossref","first-page":"61011","DOI":"10.18632\/oncotarget.17723","article-title":"Sirtuin 6 inhibits epithelial to mesenchymal transition during idiopathic pulmonary fibrosis via inactivating TGF-\u03b21\/Smad3 signaling","volume":"8","author":"Tian","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.heliyon.2022.e09773_bib157","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.taap.2019.04.013","article-title":"Sirtuin 6 inhibits MWCNTs-induced epithelial-mesenchymal transition in human bronchial epithelial cells via inactivating TGF-\u03b21\/Smad2 signaling pathway","volume":"374","author":"Chen","year":"2019","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.heliyon.2022.e09773_bib158","doi-asserted-by":"crossref","first-page":"5396","DOI":"10.1074\/jbc.M115.713123","article-title":"Loss of \u03b1-tubulin acetylation is associated with TGF-\u03b2-induced epithelial-mesenchymal transition","volume":"291","author":"Gu","year":"2016","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.heliyon.2022.e09773_bib159","doi-asserted-by":"crossref","first-page":"e0207915","DOI":"10.1371\/journal.pone.0207915","article-title":"Comparison of the antifibrotic effects of the pan-histone deacetylase-inhibitor panobinostat versus the IPF-drug pirfenidone in fibroblasts from patients with idiopathic pulmonary fibrosis","volume":"13","author":"Korfei","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.heliyon.2022.e09773_bib160","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0186615","article-title":"Tubastatin ameliorates pulmonary fibrosis by targeting the TGF\u03b2-PI3K-Akt pathway","volume":"12","author":"Saito","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.heliyon.2022.e09773_bib161","doi-asserted-by":"crossref","first-page":"33s","DOI":"10.1183\/09031936.03.00001003","article-title":"Role of coagulation cascade proteases in lung repair and fibrosis","volume":"22","author":"Chambers","year":"2003","journal-title":"Eur. Respir. J. Suppl."},{"key":"10.1016\/j.heliyon.2022.e09773_bib162","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/mi.2008.85","article-title":"Pulmonary fibrosis: pathogenesis, etiology and regulation","volume":"2","author":"Wilson","year":"2009","journal-title":"Mucosal Immunol."},{"key":"10.1016\/j.heliyon.2022.e09773_bib163","doi-asserted-by":"crossref","first-page":"136","DOI":"10.7326\/0003-4819-134-2-200101160-00015","article-title":"Idiopathic pulmonary fibrosis: prevailing and evolving hypotheses about its pathogenesis and implications for therapy","volume":"134","author":"Selman","year":"2001","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.heliyon.2022.e09773_bib164","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1136\/thoraxjnl-2013-203740","article-title":"Presence of a prothrombotic state in people with idiopathic pulmonary fibrosis: a population-based casecontrol study","volume":"69","author":"Navaratnam","year":"2014","journal-title":"Thorax"},{"key":"10.1016\/j.heliyon.2022.e09773_bib165","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.it.2003.12.005","article-title":"Chemokines: multiple levels of leukocyte migration control","volume":"25","author":"Moser","year":"2004","journal-title":"Trends Immunol."},{"key":"10.1016\/j.heliyon.2022.e09773_bib166","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1183\/16000617.00008414","article-title":"Coagulation and anticoagulation in idiopathic pulmonary fibrosis","volume":"24","author":"Crooks","year":"2015","journal-title":"Eur. Respir. Rev."},{"key":"10.1016\/j.heliyon.2022.e09773_bib167","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00100-2019","article-title":"Vascular permeability in the fibrotic lung","volume":"56","author":"Probst","year":"2020","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.heliyon.2022.e09773_bib168","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1183\/13993003.01572-2015","article-title":"The emerging role of myeloid-derived suppressor cells in lung diseases","volume":"47","author":"Kolahian","year":"2016","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.heliyon.2022.e09773_bib169","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1016\/j.ajpath.2016.03.020","article-title":"CD4(+)CD25(hi)Foxp3(+) cells exacerbate bleomycin-induced pulmonary fibrosis","volume":"186","author":"Birjandi","year":"2016","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.heliyon.2022.e09773_bib170","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1186\/s12931-018-0864-2","article-title":"Macrophages: friend or foe in idiopathic pulmonary fibrosis?","volume":"19","author":"Zhang","year":"2018","journal-title":"Respir. Res."},{"key":"10.1016\/j.heliyon.2022.e09773_bib171","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1186\/s12931-019-1216-6","article-title":"Aberrant populations of circulating T follicular helper cells and regulatory B cells underlying idiopathic pulmonary fibrosis","volume":"20","author":"Asai","year":"2019","journal-title":"Respir. Res."},{"key":"10.1016\/j.heliyon.2022.e09773_bib172","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.664109","article-title":"Dendritic cells are the intriguing players in the puzzle of idiopathic pulmonary fibrosis pathogenesis","volume":"12","author":"Bocchino","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.heliyon.2022.e09773_bib173","doi-asserted-by":"crossref","first-page":"4188","DOI":"10.4049\/jimmunol.150.9.4188","article-title":"Enhanced IL-1 beta and tumor necrosis factor-alpha release and messenger RNA expression in macrophages from idiopathic pulmonary fibrosis or after asbestos exposure","volume":"150","author":"Zhang","year":"1993","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.heliyon.2022.e09773_bib174","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1002\/emmm.201100604","article-title":"Genetic partitioning of interleukin-6 signalling in mice dissociates Stat3 from Smad3-mediated lung fibrosis","volume":"4","author":"O\u2019Donoghue","year":"2012","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.heliyon.2022.e09773_bib175","doi-asserted-by":"crossref","first-page":"43","DOI":"10.3389\/fmed.2018.00043","article-title":"The role of immune and inflammatory cells in idiopathic pulmonary fibrosis","volume":"5","author":"Desai","year":"2018","journal-title":"Front. Med."},{"key":"10.1016\/j.heliyon.2022.e09773_bib176","doi-asserted-by":"crossref","first-page":"7204","DOI":"10.18632\/oncotarget.23208","article-title":"Inflammatory responses and inflammation-associated diseases in organs","volume":"9","author":"Chen","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.heliyon.2022.e09773_bib177","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1084\/jem.170.3.727","article-title":"Macrophage production of transforming growth factor beta and fibroblast collagen synthesis in chronic pulmonary inflammation","volume":"170","author":"Khalil","year":"1989","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.heliyon.2022.e09773_bib178","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/j.cellsig.2012.01.008","article-title":"Reactive oxygen species (ROS) homeostasis and redox regulation in cellular signaling","volume":"24","author":"Ray","year":"2012","journal-title":"Cell. Signal."},{"key":"10.1016\/j.heliyon.2022.e09773_bib179","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/j.cmet.2010.11.015","article-title":"Calorie restriction reduces oxidative stress by SIRT3-mediated SOD2 activation","volume":"12","author":"Qiu","year":"2010","journal-title":"Cell Metabol."},{"key":"10.1016\/j.heliyon.2022.e09773_bib180","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1126\/science.1201940","article-title":"Mitochondria and the autophagy-inflammation-cell death axis in organismal aging","volume":"333","author":"Green","year":"2011","journal-title":"Science (New York, N.Y.)."},{"key":"10.1016\/j.heliyon.2022.e09773_bib181","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.freeradbiomed.2009.09.026","article-title":"Oxidative stress and glutathione in TGF-beta-mediated fibrogenesis","volume":"48","author":"Liu","year":"2010","journal-title":"Free Radical Biol. Med."},{"key":"10.1016\/j.heliyon.2022.e09773_bib182","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.freeradbiomed.2010.04.036","article-title":"Oxidative stress, extracellular matrix targets, and idiopathic pulmonary fibrosis","volume":"49","author":"Kliment","year":"2010","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.heliyon.2022.e09773_bib183","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1016\/j.bbadis.2012.11.021","article-title":"Oxidative stress and pulmonary fibrosis","volume":"1832","author":"Cheresh","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.heliyon.2022.e09773_bib184","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1096\/fj.99-0878com","article-title":"Ras-dependent and -independent regulation of reactive oxygen species by mitogenic growth factors and TGF-\u03b21","volume":"14","author":"Thannickal","year":"2000","journal-title":"FASEB J."},{"key":"10.1016\/j.heliyon.2022.e09773_bib185","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1038\/sj.onc.1208262","article-title":"TGF \u03b21 induces prolonged mitochondrial ROS generation through decreased complex IV activity with senescent arrest in Mv1Lu cells","volume":"24","author":"Yoon","year":"2005","journal-title":"Oncogene"},{"key":"10.1016\/j.heliyon.2022.e09773_bib186","first-page":"1077","article-title":"Redox-mediated activation of latent transforming growth factor-beta 1","volume":"10","author":"Barcellos-Hoff","year":"1996","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.heliyon.2022.e09773_bib187","first-page":"1013","volume":"84","author":"Pociask","year":"2004"},{"key":"10.1016\/j.heliyon.2022.e09773_bib188","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.redox.2015.09.009","article-title":"Reciprocal regulation of TGF-\u03b2 and reactive oxygen species: a perverse cycle for fibrosis","volume":"6","author":"Liu","year":"2015","journal-title":"Redox Biol."},{"key":"10.1016\/j.heliyon.2022.e09773_bib189","first-page":"595","article-title":"Sirtuin 3 deregulation promotes pulmonary fibrosis","volume":"72","author":"Sosulski","year":"2017","journal-title":"J.\u00a0Gerontology. Series A, Bio. Sci. Med. Sci."},{"key":"10.1016\/j.heliyon.2022.e09773_bib190","first-page":"5557","article-title":"Protective effect of SIRT3 on acute lung injury by increasing manganese superoxide dismutase-mediated antioxidation","author":"Tian","year":"2018","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.heliyon.2022.e09773_bib191","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1126\/science.273.5271.59","article-title":"Oxidative stress, caloric restriction, and aging","volume":"273","author":"Sohal","year":"1996","journal-title":"Science"},{"key":"10.1016\/j.heliyon.2022.e09773_bib192","doi-asserted-by":"crossref","first-page":"107","DOI":"10.4046\/trd.2020.0003","article-title":"Recent advances in molecular basis of lung aging and its associated diseases","volume":"83","author":"Kang","year":"2020","journal-title":"Tuberc. Respir. Dis."},{"key":"10.1016\/j.heliyon.2022.e09773_bib193","doi-asserted-by":"crossref","first-page":"21486","DOI":"10.3390\/ijms160921486","article-title":"The role of mitochondrial DNA in mediating alveolar epithelial cell apoptosis and pulmonary fibrosis","volume":"16","author":"Kim","year":"2015","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.heliyon.2022.e09773_bib194","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1021\/tx0600043","article-title":"Mechanisms of formation, genotoxicity, and mutation of guanine oxidation products","volume":"19","author":"Neeley","year":"2006","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.heliyon.2022.e09773_bib195","doi-asserted-by":"crossref","first-page":"e731","DOI":"10.1038\/cddis.2013.254","article-title":"Interaction of Sirt3 with OGG1 contributes to repair of mitochondrial DNA and protects from apoptotic cell death under oxidative stress","volume":"4","author":"Cheng","year":"2013","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.heliyon.2022.e09773_bib196","doi-asserted-by":"crossref","first-page":"L68","DOI":"10.1152\/ajplung.00188.2016","article-title":"SIRT3 blocks myofibroblast differentiation and pulmonary fibrosis by preventing mitochondrial DNA damage","volume":"312","author":"Bindu","year":"2017","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"key":"10.1016\/j.heliyon.2022.e09773_bib197","doi-asserted-by":"crossref","first-page":"69321","DOI":"10.18632\/oncotarget.12504","article-title":"SIRT3 is attenuated in systemic sclerosis skin and lungs, and its pharmacologic activation mitigates organ fibrosis","volume":"7","author":"Akamata","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.heliyon.2022.e09773_bib198","doi-asserted-by":"crossref","DOI":"10.1016\/j.pupt.2019.101803","article-title":"Probucol ameliorates EMT and lung fibrosis through restoration of SIRT3 expression","volume":"57","author":"Zhang","year":"2019","journal-title":"Pulm. Pharmacol. Therapeut."},{"key":"10.1016\/j.heliyon.2022.e09773_bib199","doi-asserted-by":"crossref","first-page":"e621","DOI":"10.1038\/cddis.2013.146","article-title":"Histone modifications are responsible for decreased Fas expression and apoptosis resistance in fibrotic lung fibroblasts","volume":"4","author":"Huang","year":"2013","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.heliyon.2022.e09773_bib200","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/s12931-018-0801-4","article-title":"Regulation of fibroblast Fas expression by soluble and mechanical pro-fibrotic stimuli","volume":"19","author":"Dodi","year":"2018","journal-title":"Respir. Res."},{"key":"10.1016\/j.heliyon.2022.e09773_bib201","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1165\/ajrcmb.21.6.3720","article-title":"Inhibition of myofibroblast apoptosis by transforming growth factor \u03b21","volume":"21","author":"Zhang","year":"1999","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.heliyon.2022.e09773_bib202","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1038\/ncponc1238","article-title":"Drug Insight: histone deacetylase inhibitor-based therapies for cutaneous T-cell lymphomas","volume":"5","author":"Khan","year":"2008","journal-title":"Nat. Clin. Pract. Oncol."},{"key":"10.1016\/j.heliyon.2022.e09773_bib203","doi-asserted-by":"crossref","first-page":"5459","DOI":"10.1200\/JCO.2009.22.1291","article-title":"Histone deacetylase inhibitors in cancer therapy","volume":"27","author":"Lane","year":"2009","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.heliyon.2022.e09773_bib204","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1111\/j.1476-5381.2010.00637.x","article-title":"Antifibrotic activity of an inhibitor of histone deacetylases in DOCA-salt hypertensive rats","volume":"159","author":"Iyer","year":"2010","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.heliyon.2022.e09773_bib205","doi-asserted-by":"crossref","first-page":"4104","DOI":"10.1158\/1078-0432.CCR-12-0055","article-title":"Cancer network disruption by a single molecule inhibitor targeting both histone deacetylase activity and Phosphatidylinositol 3-kinase signaling","volume":"18","author":"Qian","year":"2012","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.heliyon.2022.e09773_bib206","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1038\/s41419-020-02916-w","article-title":"Dual inhibition of HDAC and tyrosine kinase signaling pathways with CUDC-907 attenuates TGF\u03b21 induced lung and tumor fibrosis","volume":"11","author":"Zhang","year":"2020","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.heliyon.2022.e09773_bib207","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s43152-020-00022-9","article-title":"Origin of myofibroblasts in lung fibrosis","volume":"1","author":"Hung","year":"2020","journal-title":"Current Tissue Microenvironment Reports"},{"key":"10.1016\/j.heliyon.2022.e09773_bib208","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1165\/rcmb.2018-0313OC","article-title":"Defining the activated fibroblast population in lung fibrosis using single-cell sequencing","volume":"61","author":"Peyser","year":"2019","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.heliyon.2022.e09773_bib209","doi-asserted-by":"crossref","first-page":"e27","DOI":"10.1017\/S1462399411001967","article-title":"Myofibroblast differentiation and survival in fibrotic disease","volume":"13","author":"Kis","year":"2011","journal-title":"Expet Rev. Mol. Med."},{"key":"10.1016\/j.heliyon.2022.e09773_bib210","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1165\/rcmb.2011-0040OC","article-title":"Spiruchostatin A inhibits proliferation and differentiation of fibroblasts from patients with pulmonary fibrosis","volume":"46","author":"Davies","year":"2012","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.heliyon.2022.e09773_bib211","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.jdermsci.2003.12.006","article-title":"TGF-\u03b2-induced SMAD signaling and gene regulation: consequences for extracellular matrix remodeling and wound healing","volume":"35","author":"Schiller","year":"2004","journal-title":"J.\u00a0Dermatol. Sci."},{"key":"10.1016\/j.heliyon.2022.e09773_bib212","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1038\/nm.3777","article-title":"Orphan nuclear receptor NR4A1 regulates transforming growth factor-\u03b2 signaling and fibrosis","volume":"21","author":"Palumbo-Zerr","year":"2015","journal-title":"Nat. Med."},{"key":"10.1016\/j.heliyon.2022.e09773_bib213","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1038\/nchembio.106","article-title":"Cytosporone B is an agonist for nuclear orphan receptor Nur77","volume":"4","author":"Zhan","year":"2008","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.heliyon.2022.e09773_bib214","doi-asserted-by":"crossref","first-page":"a022061","DOI":"10.1101\/cshperspect.a022061","article-title":"TGF-\u03b2 signaling from receptors to Smads","volume":"8","author":"Hata","year":"2016","journal-title":"Cold Spring Harbor Perspect. Biol."},{"key":"10.1016\/j.heliyon.2022.e09773_bib215","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1074\/jbc.M115.694281","article-title":"Smad7 protein interacts with receptor-regulated Smads (R-Smads) to inhibit transforming growth factor-\u03b2 (TGF-\u03b2)\/Smad signaling","volume":"291","author":"Yan","year":"2016","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.heliyon.2022.e09773_bib216","doi-asserted-by":"crossref","first-page":"461","DOI":"10.3389\/fphar.2017.00461","article-title":"Targeting TGF-\u03b2 mediated SMAD signaling for the prevention of fibrosis","volume":"8","author":"Walton","year":"2017","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.heliyon.2022.e09773_bib217","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.21037\/jtd.2016.08.08","article-title":"Suberoylanilide hydroxamic acid attenuates paraquat-induced pulmonary fibrosis by preventing Smad7 from deacetylation in rats","volume":"8","author":"Rao","year":"2016","journal-title":"J.\u00a0Thorac. Dis."},{"key":"10.1016\/j.heliyon.2022.e09773_bib218","first-page":"PA4039","article-title":"Evaluation of romidepsin (FK228) as a potential therapy for idiopathic pulmonary fibrosis (IPF)","volume":"48","author":"Conforti","year":"2016","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.heliyon.2022.e09773_bib219","doi-asserted-by":"crossref","first-page":"48737","DOI":"10.18632\/oncotarget.17114","article-title":"The histone deacetylase inhibitor, romidepsin, as a potential treatment for pulmonary fibrosis","volume":"8","author":"Conforti","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.heliyon.2022.e09773_bib220","doi-asserted-by":"crossref","first-page":"L945","DOI":"10.1152\/ajplung.00473.2016","article-title":"Sirtuin 7 is decreased in pulmonary fibrosis and regulates the fibrotic phenotype of lung fibroblasts","volume":"312","author":"Wyman","year":"2017","journal-title":"Am. J. Physiol. Lung Cell. Molecular Physiol."},{"key":"10.1016\/j.heliyon.2022.e09773_bib221","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1038\/s41374-018-0161-1","article-title":"Abrogation of transforming growth factor-\u03b2-induced tissue fibrosis in mice with a global genetic deletion of Nox4","volume":"99","author":"Wermuth","year":"2019","journal-title":"Lab. Invest."},{"key":"10.1016\/j.heliyon.2022.e09773_bib222","doi-asserted-by":"crossref","first-page":"9112","DOI":"10.1073\/pnas.96.16.9112","article-title":"Leptomycin B inactivates CRM1\/exportin 1 by covalent modification at a cysteine residue in the central conserved region","volume":"96","author":"Kudo","year":"1999","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.heliyon.2022.e09773_bib223","doi-asserted-by":"crossref","first-page":"L740","DOI":"10.1152\/ajplung.00146.2010","article-title":"Hypoxia-inducible factor-1\u03b1 mediates TGF-\u03b2-induced PAI-1 production in alveolar macrophages in pulmonary fibrosis","volume":"300","author":"Ueno","year":"2011","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"key":"10.1016\/j.heliyon.2022.e09773_bib224","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1096\/fj.201500173","article-title":"The matricellular protein CCN1 enhances TGF-\u03b21\/SMAD3-dependent profibrotic signaling in fibroblasts and contributes to fibrogenic responses to lung injury","volume":"30","author":"Kurundkar","year":"2016","journal-title":"FASEB J."},{"key":"10.1016\/j.heliyon.2022.e09773_bib225","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1002\/jcb.27128","article-title":"Sirtuin 6 inhibits myofibroblast differentiation via inactivating transforming growth factor-\u03b21\/Smad2 and nuclear factor-\u03baB signaling pathways in human fetal lung fibroblasts","volume":"120","author":"Zhang","year":"2019","journal-title":"J.\u00a0Cell. Biochem."},{"key":"10.1016\/j.heliyon.2022.e09773_bib226","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1074\/jbc.RA118.007212","article-title":"Sirtuin 6 deficiency transcriptionally up-regulates TGF-\u03b2 signaling and induces fibrosis in mice","volume":"295","author":"Maity","year":"2020","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.heliyon.2022.e09773_bib227","doi-asserted-by":"crossref","first-page":"L615","DOI":"10.1152\/ajplung.00185.2015","article-title":"FGF9 and FGF18 in idiopathic pulmonary fibrosis promote survival and migration and inhibit myofibroblast differentiation of human lung fibroblasts in vitro","volume":"310","author":"Joannes","year":"2016","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"key":"10.1016\/j.heliyon.2022.e09773_bib228","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/nm.4447","article-title":"Thyroid hormone inhibits lung fibrosis in mice by improving epithelial mitochondrial function","volume":"24","author":"Yu","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.heliyon.2022.e09773_bib229","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1007\/s40291-020-00490-7","article-title":"More than a genetic code: epigenetics of lung fibrosis","volume":"24","author":"Bartczak","year":"2020","journal-title":"Mol. Diagn. Ther."},{"key":"10.1016\/j.heliyon.2022.e09773_bib230","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1038\/onc.2012.191","article-title":"Genome-wide mechanisms of Smad binding","volume":"32","author":"Morikawa","year":"2013","journal-title":"Oncogene"},{"key":"10.1016\/j.heliyon.2022.e09773_bib231","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.105027","article-title":"AGK2 ameliorates mast cell-mediated allergic airway inflammation and fibrosis by inhibiting Fc\u03b5RI\/TGF-\u03b2 signaling pathway","volume":"159","author":"Kim","year":"2020","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.heliyon.2022.e09773_bib232","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.756131","article-title":"Inhibition of Sirt2 alleviates fibroblasts activation and pulmonary fibrosis via Smad2\/3 pathway","volume":"12","author":"Gong","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.heliyon.2022.e09773_bib233","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/1755-1536-6-20","article-title":"Matrix regulation of idiopathic pulmonary fibrosis: the role of enzymes","volume":"6","author":"Clarke","year":"2013","journal-title":"Fibrogenesis Tissue Repair"},{"key":"10.1016\/j.heliyon.2022.e09773_bib234","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1007\/s00418-018-1747-9","article-title":"The micromechanics of lung alveoli: structure and function of surfactant and tissue components","volume":"150","author":"Knudsen","year":"2018","journal-title":"Histochem. Cell Biol."},{"key":"10.1016\/j.heliyon.2022.e09773_bib235","doi-asserted-by":"crossref","first-page":"L709","DOI":"10.1152\/ajplung.00418.2012","article-title":"Always cleave up your mess: targeting collagen degradation to treat tissue fibrosis","volume":"304","author":"McKleroy","year":"2013","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"key":"10.1016\/j.heliyon.2022.e09773_bib236","doi-asserted-by":"crossref","first-page":"10364","DOI":"10.1074\/jbc.M117.791764","article-title":"Pulmonary fibrosis requires cell-autonomous mesenchymal fibroblast growth factor (FGF) signaling","volume":"292","author":"Guzy","year":"2017","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.heliyon.2022.e09773_bib237","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0033-2018","article-title":"Matrix abnormalities in pulmonary fibrosis","volume":"27","author":"Upagupta","year":"2018","journal-title":"Eur. Respir. Rev."},{"key":"10.1016\/j.heliyon.2022.e09773_bib238","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1128\/MCB.22.5.1352-1359.2002","article-title":"Integrin alpha 2 beta 1 promotes activation of protein phosphatase 2A and dephosphorylation of Akt and glycogen synthase kinase 3 beta","volume":"22","author":"Ivaska","year":"2002","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.heliyon.2022.e09773_bib239","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1091\/mbc.e07-06-0623","article-title":"PP2A regulates HDAC4 nuclear import","volume":"19","author":"Paroni","year":"2008","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.heliyon.2022.e09773_bib240","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1165\/rcmb.2010-0323OC","article-title":"miR-29 is a major regulator of genes associated with pulmonary fibrosis","volume":"45","author":"Cushing","year":"2011","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.heliyon.2022.e09773_bib241","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1172\/JCI89548","article-title":"Activation of tumor suppressor protein PP2A inhibits KRAS-driven tumor growth","volume":"127","author":"Sangodkar","year":"2017","journal-title":"J.\u00a0Clin. Investig."},{"key":"10.1016\/j.heliyon.2022.e09773_bib242","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1186\/s12931-019-1192-x","article-title":"Protein phosphatase 2A (PP2A): a key phosphatase in the progression of chronic obstructive pulmonary disease (COPD) to lung cancer","volume":"20","author":"Nader","year":"2019","journal-title":"Respir. Res."},{"key":"10.1016\/j.heliyon.2022.e09773_bib243","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1165\/rcmb.2016-0192OC","article-title":"Sirtuin1 protects against systemic sclerosis-related pulmonary fibrosis by decreasing proinflammatory and profibrotic processes","volume":"58","author":"Chu","year":"2018","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.heliyon.2022.e09773_bib244","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/j.bbrc.2017.03.155","article-title":"Activation and overexpression of Sirt1 attenuates lung fibrosis via P300","volume":"486","author":"Zeng","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.heliyon.2022.e09773_bib245","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1038\/s41467-019-10066-7","article-title":"Inactivation of nuclear histone deacetylases by EP300 disrupts the MiCEE complex in idiopathic pulmonary fibrosis","volume":"10","author":"Rubio","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.heliyon.2022.e09773_bib246","doi-asserted-by":"crossref","first-page":"34901","DOI":"10.1074\/jbc.M109.038356","article-title":"Trans-regulation of histone deacetylase activities through acetylation","volume":"284","author":"Luo","year":"2009","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.heliyon.2022.e09773_bib247","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1038\/s41588-018-0139-3","article-title":"MiCEE is a ncRNA-protein complex that mediates epigenetic silencing and nucleolar organization","volume":"50","author":"Singh","year":"2018","journal-title":"Nat. Genet."},{"key":"10.1016\/j.heliyon.2022.e09773_bib248","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1097\/01.LAB.0000032380.82232.67","article-title":"Abnormal re-epithelialization and lung remodeling in idiopathic pulmonary fibrosis: the role of \u0394N-p63","volume":"82","author":"Chilosi","year":"2002","journal-title":"Lab. Invest."},{"key":"10.1016\/j.heliyon.2022.e09773_bib249","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1038\/s41374-019-0189-x","article-title":"Surfactant dysfunction and alveolar collapse are linked with fibrotic septal wall remodeling in the TGF-\u03b21-induced mouse model of pulmonary fibrosis","volume":"99","author":"Beike","year":"2019","journal-title":"Lab. Invest."},{"key":"10.1016\/j.heliyon.2022.e09773_bib250","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1164\/rccm.201508-1638OC","article-title":"Stretch-induced activation of transforming growth factor-\u03b21 in pulmonary fibrosis","volume":"194","author":"Froese","year":"2016","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.heliyon.2022.e09773_bib251","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/j.bbrc.2018.04.003","article-title":"TGF beta inhibits expression of SP-A, SP-B, SP-C, but not SP-D in human alveolar type II cells","volume":"499","author":"Correll","year":"2018","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.heliyon.2022.e09773_bib252","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1165\/rcmb.2014-0078OC","article-title":"Alveolar derecruitment and collapse induration as crucial mechanisms in lung injury and fibrosis","volume":"52","author":"Lutz","year":"2015","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.heliyon.2022.e09773_bib253","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1586\/17476348.2015.1067609","article-title":"Permanent alveolar collapse is the predominant mechanism in idiopathic pulmonary fibrosis","volume":"9","author":"Todd","year":"2015","journal-title":"Expet Rev. Respir. Med."},{"key":"10.1016\/j.heliyon.2022.e09773_bib254","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1164\/ajrccm\/140.2.513","article-title":"Alveolitis and collapse in the pathogenesis of pulmonary fibrosis","volume":"140","author":"Burkhardt","year":"1989","journal-title":"Am. Rev. Respir. Dis."},{"key":"10.1016\/j.heliyon.2022.e09773_bib255","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1164\/rccm.201902-0451OC","article-title":"Grp78 loss in epithelial progenitors reveals an age-linked role for endoplasmic reticulum stress in pulmonary fibrosis","volume":"201","author":"Borok","year":"2020","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.heliyon.2022.e09773_bib256","doi-asserted-by":"crossref","first-page":"13156","DOI":"10.1096\/fj.202001607R","article-title":"The cGAS-STING pathway: the role of self-DNA sensing in inflammatory lung disease","volume":"34","author":"Ma","year":"2020","journal-title":"FASEB J."},{"key":"10.1016\/j.heliyon.2022.e09773_bib257","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1042\/CS20191160","article-title":"Self DNA perpetuates IPF lung fibroblast senescence in a cGAS-dependent manner","volume":"134","author":"Schuliga","year":"2020","journal-title":"Clin. Sci."},{"key":"10.1016\/j.heliyon.2022.e09773_bib258","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.642855","article-title":"The NLRP3-inflammasome-caspase-1 pathway is upregulated in idiopathic pulmonary fibrosis and acute exacerbations and is inducible by apoptotic A549 cells","volume":"12","author":"J\u00e4ger","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.heliyon.2022.e09773_bib259","doi-asserted-by":"crossref","first-page":"9644","DOI":"10.7150\/thno.47651","article-title":"HDAC3 inhibition ameliorates ischemia\/reperfusion-induced brain injury by regulating the microglial cGAS-STING pathway","volume":"10","author":"Liao","year":"2020","journal-title":"Theranostics"},{"key":"10.1016\/j.heliyon.2022.e09773_bib260","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/j.bbrc.2015.10.033","article-title":"Histone deacetylase 6 negatively regulates NLRP3 inflammasome activation","volume":"467","author":"Hwang","year":"2015","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.heliyon.2022.e09773_bib261","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1164\/rccm.202004-1274OC","article-title":"Senescence of alveolar type 2 cells drives progressive pulmonary fibrosis","volume":"203","author":"Yao","year":"2021","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.heliyon.2022.e09773_bib262","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1186\/s13287-021-02215-x","article-title":"Inhibition of miR-199a-5p rejuvenates aged mesenchymal stem cells derived from patients with idiopathic pulmonary fibrosis and improves their therapeutic efficacy in experimental pulmonary fibrosis","volume":"12","author":"Shi","year":"2021","journal-title":"Stem Cell Res. Ther."},{"key":"10.1016\/j.heliyon.2022.e09773_bib263","doi-asserted-by":"crossref","first-page":"5177","DOI":"10.1021\/pr800510p","article-title":"Quantitative analysis of histone deacetylase-1 selective histone modifications by differential mass spectrometry","volume":"7","author":"Lee","year":"2008","journal-title":"J.\u00a0Proteome Res."},{"key":"10.1016\/j.heliyon.2022.e09773_bib264","first-page":"166","article-title":"Histone deacetylase inhibitors: molecular mechanisms of action and clinical trials as anti-cancer drugs","volume":"3","author":"Kim","year":"2011","journal-title":"Am. J. Transl. Res."},{"key":"10.1016\/j.heliyon.2022.e09773_bib265","doi-asserted-by":"crossref","first-page":"505","DOI":"10.4155\/fmc.12.3","article-title":"Targeted cancer therapy: giving histone deacetylase inhibitors all they need to succeed","volume":"4","author":"Gryder","year":"2012","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.heliyon.2022.e09773_bib266","doi-asserted-by":"crossref","first-page":"2630","DOI":"10.3390\/ijms19092630","article-title":"Histone deacetylase inhibitors and diabetic kidney disease","volume":"19","author":"Hadden","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.heliyon.2022.e09773_bib267","doi-asserted-by":"crossref","first-page":"715","DOI":"10.3390\/molecules27030715","article-title":"HDAC inhibitors: innovative strategies for their design and applications","volume":"27","author":"Da\u015bko","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.heliyon.2022.e09773_bib268","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1042\/bj20021321","article-title":"Histone deacetylases (HDACs): characterization of the classical HDAC family","volume":"370","author":"de Ruijter","year":"2003","journal-title":"Biochem. J."},{"key":"10.1016\/j.heliyon.2022.e09773_bib269","doi-asserted-by":"crossref","first-page":"388","DOI":"10.2174\/138920107783018417","article-title":"Histone deacetylase inhibitors in cancer treatment: a review of the clinical toxicity and the modulation of gene expression in cancer cells","volume":"8","author":"Bruserud","year":"2007","journal-title":"Curr. Pharmaceut. Biotechnol."},{"key":"10.1016\/j.heliyon.2022.e09773_bib270","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s12035-009-8067-y","article-title":"Focal nature of neurological disorders necessitates isotype-selective histone deacetylase (HDAC) inhibitors","volume":"40","author":"Thomas","year":"2009","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.heliyon.2022.e09773_bib271","doi-asserted-by":"crossref","first-page":"9960","DOI":"10.1021\/acs.jmedchem.1c00184","article-title":"Harnessing the role of HDAC6 in idiopathic pulmonary fibrosis: design, synthesis, structural analysis, and biological evaluation of potent inhibitors","volume":"64","author":"Campiani","year":"2021","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.heliyon.2022.e09773_bib272","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-67112-4","article-title":"Hydroxamic acid derivatives as HDAC1, HDAC6 and HDAC8 inhibitors with antiproliferative activity in cancer cell lines","volume":"10","author":"Sixto-L\u00f3pez","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.heliyon.2022.e09773_bib273","doi-asserted-by":"crossref","first-page":"19571","DOI":"10.1039\/C9RA02985K","article-title":"Next-generation of selective histone deacetylase inhibitors","volume":"9","author":"Yang","year":"2019","journal-title":"RSC Adv."},{"key":"10.1016\/j.heliyon.2022.e09773_bib274","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2020.607689","article-title":"Nanoapproaches to modifying epigenetics of epithelial mesenchymal transition for treatment of pulmonary fibrosis","volume":"11","author":"Skibba","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.heliyon.2022.e09773_bib275","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.3390\/ijms18071414","article-title":"Histone deacetylase inhibitors as anticancer drugs","volume":"18","author":"Eckschlager","year":"2017","journal-title":"Int. J. Mol. Sci."}],"updated-by":[{"DOI":"10.1016\/j.heliyon.2022.e12694","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000}}],"container-title":["Heliyon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844022010611?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844022010611?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T09:08:04Z","timestamp":1772010484000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405844022010611"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":275,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2022,8]]}},"alternative-id":["S2405844022010611"],"URL":"https:\/\/doi.org\/10.1016\/j.heliyon.2022.e09773","relation":{},"ISSN":["2405-8440"],"issn-type":[{"value":"2405-8440","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Specific epigenetic regulators serve as potential therapeutic targets in idiopathic pulmonary fibrosis","name":"articletitle","label":"Article Title"},{"value":"Heliyon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.heliyon.2022.e09773","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e09773"}}